Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Vomiting 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Skin Neoplasms 1Prostate Cancer Prevention 1Postoperative Nausea and Vomiting 1Multiple Endocrine Neoplasia Type 1 1Healthy Volunteers 1Dermatitis, Contact 1Colorectal Neoplasms 1Breast Neoplasms 1Atypical Squamous Cells of the Cervix 1

Interventions

pembrolizumab 23Nivolumab 22aldesleukin 21Cyclophosphamide 20Ipilimumab 17Interleukin-2 17fludarabine 15fludarabine phosphate 14cemiplimab 12Radiotherapy 7Fluorouracil 7Dacarbazine 6binimetinib 5Vemurafenib 5Temozolomide 5Surgical Procedures, Operative 5Sirolimus 5Radiation 5Biopsy 5Aminolevulinic Acid 5encorafenib 4dabrafenib 4Photochemotherapy 4Educational Status 4trametinib 3sonidegib 3montanide ISA 51 3avelumab 3Tacrolimus 3Sodium Chloride 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Skin Neoplasms × Gelatin × Clear all
NCT01032343 2013-08-22

An Immunonutritional Approach to the Prevention of Skin Cancer

University of Manchester

Phase NA Completed
90 enrolled
Dermatologic

Dermatitis, Contact, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡